Charles Schwab Investment Management Inc Veracyte, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 720,969 shares of VCYT stock, worth $30 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
720,969
Previous 735,007 1.91%
Holding current value
$30 Million
Previous $25 Million 14.15%
% of portfolio
0.01%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$31.92 - $44.4 $448,092 - $623,287
-14,038 Reduced 1.91%
720,969 $28.6 Million
Q3 2024

Nov 12, 2024
SELL
$21.0 - $35.25 $568,890 - $954,922
-27,090 Reduced 3.55%
735,007 $25 Million
Q2 2024

Aug 12, 2024
BUY
$18.86 - $23.55 $553,012 - $690,533
29,322 Added 4.0%
762,097 $16.5 Million
Q1 2024

May 08, 2024
BUY
$21.0 - $29.1 $721,497 - $999,788
34,357 Added 4.92%
732,775 $16.2 Million
Q4 2023

Feb 06, 2024
BUY
$19.72 - $28.68 $277,381 - $403,412
14,066 Added 2.06%
698,418 $19.2 Million
Q3 2023

Nov 08, 2023
SELL
$22.33 - $29.92 $71,612 - $95,953
-3,207 Reduced 0.47%
684,352 $15.3 Million
Q2 2023

Aug 09, 2023
BUY
$20.96 - $26.99 $737,917 - $950,209
35,206 Added 5.4%
687,559 $17.5 Million
Q1 2023

May 11, 2023
BUY
$20.58 - $27.89 $2,407 - $3,263
117 Added 0.02%
652,353 $14.5 Million
Q4 2022

Feb 13, 2023
BUY
$15.31 - $29.94 $179,555 - $351,136
11,728 Added 1.83%
652,236 $15.5 Million
Q3 2022

Nov 14, 2022
BUY
$16.58 - $27.9 $1.67 Million - $2.82 Million
100,995 Added 18.72%
640,508 $10.6 Million
Q2 2022

Aug 15, 2022
BUY
$15.45 - $29.52 $485,856 - $928,315
31,447 Added 6.19%
539,513 $10.7 Million
Q1 2022

May 13, 2022
BUY
$21.94 - $42.51 $51,646 - $100,068
2,354 Added 0.47%
508,066 $14 Million
Q4 2021

Feb 11, 2022
BUY
$36.09 - $53.79 $439,648 - $655,269
12,182 Added 2.47%
505,712 $20.8 Million
Q3 2021

Nov 16, 2021
BUY
$35.62 - $52.97 $729,640 - $1.09 Million
20,484 Added 4.33%
493,530 $22.9 Million
Q2 2021

Aug 16, 2021
BUY
$32.94 - $56.62 $21,707 - $37,312
659 Added 0.14%
473,046 $18.9 Million
Q1 2021

May 17, 2021
BUY
$44.47 - $81.38 $3.26 Million - $5.96 Million
73,284 Added 18.36%
472,387 $25.4 Million
Q4 2020

Feb 16, 2021
BUY
$32.49 - $61.88 $333,379 - $634,950
10,261 Added 2.64%
399,103 $19.5 Million
Q3 2020

Nov 13, 2020
BUY
$26.73 - $35.67 $1.54 Million - $2.06 Million
57,666 Added 17.41%
388,842 $12.6 Million
Q2 2020

Aug 14, 2020
SELL
$19.49 - $28.11 $603,995 - $871,128
-30,990 Reduced 8.56%
331,176 $8.58 Million
Q1 2020

May 15, 2020
SELL
$16.13 - $30.17 $598,358 - $1.12 Million
-37,096 Reduced 9.29%
362,166 $8.81 Million
Q4 2019

Feb 07, 2020
SELL
$20.78 - $29.99 $202,771 - $292,642
-9,758 Reduced 2.39%
399,262 $11.1 Million
Q3 2019

Nov 08, 2019
BUY
$23.87 - $30.93 $4.47 Million - $5.79 Million
187,257 Added 84.44%
409,020 $9.82 Million
Q2 2019

Aug 09, 2019
BUY
$22.1 - $28.56 $1.23 Million - $1.59 Million
55,652 Added 33.5%
221,763 $6.32 Million
Q1 2019

May 14, 2019
BUY
$12.0 - $25.76 $621,144 - $1.33 Million
51,762 Added 45.27%
166,111 $4.16 Million
Q4 2018

Feb 14, 2019
BUY
$9.15 - $14.85 $50,068 - $81,259
5,472 Added 5.03%
114,349 $1.44 Million
Q3 2018

Nov 13, 2018
SELL
$9.55 - $12.64 $319,027 - $422,251
-33,406 Reduced 23.48%
108,877 $1.04 Million
Q2 2018

Aug 08, 2018
SELL
$5.39 - $9.66 $132,556 - $237,568
-24,593 Reduced 14.74%
142,283 $1.33 Million
Q4 2017

Jan 17, 2018
BUY
$6.05 - $9.37 $26,099 - $40,422
4,314 Added 2.65%
166,876 $1.09 Million
Q3 2017

Nov 13, 2017
BUY
$7.81 - $8.77 $1.27 Million - $1.43 Million
162,562
162,562 $1.43 Million

Others Institutions Holding VCYT

# of Institutions
322
Shares Held
79.4M
Call Options Held
134K
Put Options Held
13.3K
View Full List

About VERACYTE, INC.

VCYT Quotes by TradingView
  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.97B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email